{"meta":{"query_hash":"4338ff23aa9b","filters":{"venue":"Clinical Pharmacology Advances and Applications"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4338ff23aa9b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Pharmacology+Advances+and+Applications"},"results":[{"id":"W2075428150","doi":"10.2147/cpaa.s64131","title":"Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology Advances and Applications","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Digoxin; Pharmacokinetics; Pharmacology; Therapeutic index; Medicine; Active metabolite; Tolerability; Chemistry; Metabolite; Oral administration; Urine; Drug; Endocrinology; Internal medicine; Adverse effect; Heart failure","score_opus":0.039659122879576195,"score_gpt":0.42283517403519394,"score_spread":0.38317605115561776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075428150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997116,0.00039334077,0.0004124575,0.0009150814,0.00017888378,0.0007786066,0.00010890591,0.0000044949384,0.00009217433],"genre_scores_gemma":[0.99780834,0.0012978389,0.00008200905,0.00019777045,0.00025580497,0.00013484643,0.00018081986,0.00000848747,0.00003407627],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838126,0.00035524656,0.000767403,0.0002978742,0.00009379513,0.00010444561],"domain_scores_gemma":[0.9983082,0.00090516586,0.00046117997,0.00021028248,0.00006954296,0.00004566209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090852333,0.00011603881,0.0003100097,0.00004345712,0.000038997,0.0000017292722,0.00016013235,0.00007128577,0.000014560736],"category_scores_gemma":[0.000091807065,0.00008455335,0.00007314034,0.0001303152,0.00025831096,0.000006035548,0.00004217448,0.00017043228,0.0000012760659],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019919064,0.008936843,0.46879762,0.00063000707,0.00073945173,8.686353e-7,0.0015330152,0.008485571,0.35597935,0.00053413573,0.007228892,0.12721519],"study_design_scores_gemma":[0.02459274,0.0061759613,0.17460209,0.00013459894,0.0005803439,0.0000011754795,0.0006896153,0.0013737915,0.53788364,0.0013151689,0.2521516,0.00049926],"about_ca_topic_score_codex":0.00001980397,"about_ca_topic_score_gemma":0.000046835026,"teacher_disagreement_score":0.29419553,"about_ca_system_score_codex":0.0000040789796,"about_ca_system_score_gemma":0.000017122791,"threshold_uncertainty_score":0.34479854},"labels":[],"label_agreement":null},{"id":"W2507259647","doi":"10.2147/cpaa.s105165","title":"Systematic review and network meta-analysis of stroke-prevention treatments in patients with atrial fibrillation","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology Advances and Applications","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; Cancer Care Ontario; University of Toronto; St. Michael's Hospital; Toronto Public Health","funders":"University of Toronto; Government of Ontario","keywords":"Medicine; Edoxaban; Apixaban; Dabigatran; Warfarin; Rivaroxaban; Atrial fibrillation; Stroke (engine); Aspirin; Internal medicine; Hazard ratio; Clopidogrel; Randomized controlled trial; Anesthesia; Cardiology; Confidence interval","score_opus":0.09936278694505525,"score_gpt":0.45675288756865956,"score_spread":0.3573901006236043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507259647","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4436731,0.48679182,0.019892046,0.017488472,0.00036540243,0.03083584,0.0002752019,0.00013808646,0.0005400061],"genre_scores_gemma":[0.89847463,0.096293256,0.0018786957,0.000807651,0.0005838167,0.00015962675,0.00013387384,0.000018932993,0.0016495287],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9987633,0.00014223476,0.0006991022,0.00022157356,0.00008702033,0.00008673234],"domain_scores_gemma":[0.9986674,0.0006743069,0.0004105559,0.0001270404,0.00006631149,0.000054369524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035622792,0.00009278104,0.0012189723,0.00007566562,0.000036932714,0.0000024000933,0.000028267948,0.000042399493,0.000092187714],"category_scores_gemma":[0.000052358544,0.00004945909,0.0003382108,0.00031291557,0.00008951603,0.00009217512,0.000023268545,0.0000338727,0.0000022059435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002643621,0.000032555254,0.9392617,0.0055457493,0.05106961,2.1097415e-7,0.000003139149,0.00013386337,0.0000033607005,0.0003534242,0.000052594518,0.0032794361],"study_design_scores_gemma":[0.004230397,0.0003665066,0.35914204,0.00043204572,0.6330872,2.5895272e-7,0.0000043054592,0.000065145796,0.0000021229475,0.00030414367,0.0022582917,0.000107505635],"about_ca_topic_score_codex":7.4203456e-7,"about_ca_topic_score_gemma":0.0000036052045,"teacher_disagreement_score":0.5820176,"about_ca_system_score_codex":0.000011078425,"about_ca_system_score_gemma":0.000009461291,"threshold_uncertainty_score":0.20168832},"labels":[],"label_agreement":null},{"id":"W4200179740","doi":"10.2147/cpaa.s288842","title":"Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology Advances and Applications","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Muscular Dystrophy Canada; Alberta Innovates; Alberta Innovates - Health Solutions; Women and Children's Health Research Institute; Children's Health Research Institute","keywords":"Duchenne muscular dystrophy; Exon skipping; Dystrophin; Medicine; Muscular dystrophy; Muscle disorder; Clinical trial; Exon; Bioinformatics; Internal medicine; Genetics; Gene; Biology","score_opus":0.0735950491683823,"score_gpt":0.4762422176833558,"score_spread":0.4026471685149735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200179740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002991754,0.9937225,0.0005968115,0.00004673659,0.0002458869,0.002123613,0.00023585156,0.0000058410606,0.000030979998],"genre_scores_gemma":[0.0019163839,0.9911458,0.00040730968,0.00009690864,0.000572725,0.005450081,0.00030882974,0.000016868427,0.000085121515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982761,0.00020500398,0.0007178165,0.0005580674,0.00004717223,0.00019584961],"domain_scores_gemma":[0.9983219,0.00069872825,0.00047277356,0.00030403843,0.00012325923,0.00007930955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014306018,0.00024903603,0.0010133812,0.000021085956,0.00013098888,0.0000031726602,0.00028485525,0.00032083745,0.00006387143],"category_scores_gemma":[0.00004722611,0.00015816667,0.0006007505,0.00011455474,0.0009333578,0.0000041321937,0.00008467093,0.00012838349,0.0000013690321],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020248031,0.0017516097,0.000022862776,0.0019851667,0.0011512537,0.0000011394441,0.000043128006,0.00002525121,0.0029553114,0.00016724449,0.00067294226,0.99102163],"study_design_scores_gemma":[0.0007828715,0.00081302796,0.000011553814,0.000053803124,0.0013180602,0.00000458725,0.00008626099,0.000015806987,0.00053940323,0.00003550585,0.99619085,0.00014829668],"about_ca_topic_score_codex":0.0000023155014,"about_ca_topic_score_gemma":0.000001422059,"teacher_disagreement_score":0.9955179,"about_ca_system_score_codex":0.000007031771,"about_ca_system_score_gemma":0.00012749458,"threshold_uncertainty_score":0.644985},"labels":[],"label_agreement":null},{"id":"W4410326796","doi":"10.2147/cpaa.s509476","title":"Predictive Analysis of Non-Cardiac Drug-Induced QTc Interval Prolongation: A Cross-Sectional Study","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology Advances and Applications","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"King Abdullah International Medical Research Center","keywords":"Prolongation; QT interval; Medicine; Cross-sectional study; Internal medicine; Drug; Cardiology; Interval (graph theory); Pharmacology; Mathematics; Pathology; Combinatorics","score_opus":0.022311847070751057,"score_gpt":0.4537111245587702,"score_spread":0.43139927748801915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410326796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937705,0.0007403598,0.0021258313,0.00043919386,0.0004662705,0.0014630571,0.00004524926,0.000035764606,0.00091378274],"genre_scores_gemma":[0.9969937,0.00045926255,0.0001378751,0.00053225027,0.0005050182,0.0009769464,0.00005560591,0.0000055113537,0.00033379896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848366,0.00015336442,0.00064915925,0.00047283393,0.000087961875,0.00015303126],"domain_scores_gemma":[0.99858904,0.00069271703,0.00019209387,0.00020512694,0.00023764599,0.00008336871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045383826,0.00012285431,0.0006527897,0.00018390085,0.00018026734,0.0000060879124,0.000081838734,0.00012044102,0.00004910864],"category_scores_gemma":[0.000052049458,0.00010900416,0.00034863013,0.0008111735,0.00042936174,0.00007246604,0.00007930535,0.00039718876,0.00000551501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009899277,0.0011340693,0.98095274,0.0000488431,0.00470087,0.0000041609696,0.000057860114,0.000356124,0.0027289896,0.0002094602,0.0004012588,0.00841571],"study_design_scores_gemma":[0.0015548432,0.0004945276,0.98945934,0.000005677854,0.0031236634,0.0000019450292,0.000087500564,0.00133889,0.0005116579,0.00035268144,0.0029936198,0.00007566931],"about_ca_topic_score_codex":0.00000443247,"about_ca_topic_score_gemma":0.000003945195,"teacher_disagreement_score":0.008506598,"about_ca_system_score_codex":0.00002476862,"about_ca_system_score_gemma":0.000105838895,"threshold_uncertainty_score":0.44450608},"labels":[],"label_agreement":null}]}